We have observed
6 EP applications
Helen Kaye Quillin
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 21, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS
THIENO[3,2-D]PYRIMIDINE-6-CARBOXAMIDES AND ANALOGUES AS SIRTUIN MODULATORS
SIRTUIN ACTIVATORS AND ACTIVATION ASSAYS
SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS